{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:32:16Z","timestamp":1789705936216,"version":"4.0.1"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1681\/asn.2013111185","type":"journal-article","created":{"date-parts":[[2014,9,5]],"date-time":"2014-09-05T21:42:41Z","timestamp":1409953361000},"page":"1205-1214","source":"Crossref","is-referenced-by-count":59,"title":["Paricalcitol for Secondary Hyperparathyroidism in Renal Transplantation"],"prefix":"10.1681","volume":"26","author":[{"given":"Matias","family":"Trillini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Cortinovis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Ruggenenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Reyes Loaeza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Courville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Ferrer-Siles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Prandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Gaspari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cannata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Perna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Gotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosa","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Martinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norberto","family":"Perico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-25-20230208","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0272-6386(96)90138-9","article-title":"Long-term bone loss in kidney transplant recipients: A cross-sectional and longitudinal study.","volume":"28","author":"Pichette","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"R2-25-20230208","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0272-6386(12)70118-X","article-title":"Musculoskeletal complications after renal transplantation: Pathogenesis and treatment.","volume":"19","author":"Julian","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"R3-25-20230208","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/00007890-199410270-00009","article-title":"Bone fracture and osteodensitometry with dual energy X-ray absorptiometry in kidney transplant recipients.","volume":"58","author":"Grotz","year":"1994","journal-title":"Transplantation"},{"key":"R4-25-20230208","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1001\/jama.288.23.3014","article-title":"Risk of hip fracture among dialysis and renal transplant recipients.","volume":"288","author":"Ball","year":"2002","journal-title":"JAMA"},{"key":"R5-25-20230208","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1047-2797(01)00226-5","article-title":"Hospitalizations for fractures after renal transplantation in the United States.","volume":"11","author":"Abbott","year":"2001","journal-title":"Ann Epidemiol"},{"key":"R6-25-20230208","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1600-6143.2011.03872.x","article-title":"Reduced fracture risk with early corticosteroid withdrawal after kidney transplant.","volume":"12","author":"Nikkel","year":"2012","journal-title":"Am J Transplant"},{"key":"R7-25-20230208","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2215\/CJN.01510506","article-title":"Bone disease after renal transplantation.","volume":"1","author":"Weisinger","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R8-25-20230208","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/01.tp.0000230130.50451.78","article-title":"Impact of parathyroid hormone on bone density in long-term renal transplant patients with good graft function.","volume":"82","author":"Akaberi","year":"2006","journal-title":"Transplantation"},{"key":"R9-25-20230208","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/01.TP.0000043926.74349.6D","article-title":"Bone disease after renal transplantation.","volume":"75","author":"Heaf","year":"2003","journal-title":"Transplantation"},{"key":"R10-25-20230208","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/oxfordjournals.ndt.a027676","article-title":"Bone demineralization after renal transplantation: Contribution of secondary hyperparathyroidism manifested by hypercalcaemia.","volume":"11","author":"Setterberg","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"R11-25-20230208","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00198-004-1653-y","article-title":"Reduced bone mineral density in male renal transplant recipients: Evidence for persisting hyperparathyroidism.","volume":"16","author":"Roe","year":"2005","journal-title":"Osteoporos Int"},{"key":"R12-25-20230208","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1681\/ASN.V132551","article-title":"Calcium metabolism and skeletal problems after transplantation.","volume":"13","author":"Torres","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R13-25-20230208","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ki.1989.36","article-title":"1,25(OH)2D3 administration in moderate renal failure: A prospective double-blind trial.","volume":"35","author":"Baker","year":"1989","journal-title":"Kidney Int"},{"key":"R14-25-20230208","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000073945","article-title":"Management of secondary hyperparathyroidism: The importance and the challenge of controlling parathyroid hormone levels without elevating calcium, phosphorus, and calcium-phosphorus product.","volume":"23","author":"Moe","year":"2003","journal-title":"Am J Nephrol"},{"key":"R15-25-20230208","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1046\/j.1523-1755.2003.00878.x","article-title":"Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism.","volume":"63","author":"Sprague","year":"2003","journal-title":"Kidney Int"},{"key":"R16-25-20230208","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy.","volume":"349","author":"Teng","year":"2003","journal-title":"N Engl J Med"},{"key":"R17-25-20230208","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(10)61032-X","article-title":"Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): A randomised controlled trial.","volume":"376","author":"de Zeeuw","year":"2010","journal-title":"Lancet"},{"key":"R18-25-20230208","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1111\/j.1523-1755.2005.00755.x","article-title":"Antiproteinuric effect of oral paricalcitol in chronic kidney disease.","volume":"68","author":"Agarwal","year":"2005","journal-title":"Kidney Int"},{"key":"R19-25-20230208","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1097\/TP.0b013e3182855565","article-title":"Effects of oral paricalcitol on secondary hyperparathyroidism and proteinuria of kidney transplant patients.","volume":"95","author":"Gonzalez","year":"2013","journal-title":"Transplantation"},{"key":"R20-25-20230208","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/ajt.12227","article-title":"Oral paricalcitol reduces the prevalence of posttransplant hyperparathyroidism: Results of an open label randomized trial.","volume":"13","author":"Amer","year":"2013","journal-title":"Am J Transplant"},{"key":"R21-25-20230208","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1093\/ndt\/gft227","article-title":"Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: Results of the VITAL study.","volume":"28","author":"Coyne","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R22-25-20230208","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1185\/030079905X49635","article-title":"Clinical use of serum and urine bone markers in the management of osteoporosis.","volume":"21","author":"Srivastava","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"R23-25-20230208","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1161\/ATVBAHA.111.230904","article-title":"Bone Gla protein increases HIF-1alpha-dependent glucose metabolism and induces cartilage and vascular calcification.","volume":"31","author":"Idelevich","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R24-25-20230208","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1161\/ATVBAHA.107.147868","article-title":"Role of osteoprotegerin in arterial calcification: Development of new animal model.","volume":"27","author":"Orita","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R25-25-20230208","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1359\/jbmr.080610","article-title":"Bone markers predict cardiovascular events in chronic kidney disease.","volume":"23","author":"Fahrleitner-Pammer","year":"2008","journal-title":"J Bone Miner Res"},{"key":"R26-25-20230208","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.2215\/CJN.10091110","article-title":"Bone alkaline phosphatase and mortality in dialysis patients.","volume":"6","author":"Drechsler","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R27-25-20230208","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.ki.5002572","article-title":"Renoprotective role of the vitamin D receptor in diabetic nephropathy.","volume":"73","author":"Zhang","year":"2008","journal-title":"Kidney Int"},{"key":"R28-25-20230208","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1681\/ASN.2006091028","article-title":"Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.","volume":"18","author":"Mizobuchi","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R29-25-20230208","first-page":"716","article-title":"Vitamin D and proteinuria: A critical review of molecular bases and clinical experience.","volume":"33","author":"P\u00e9rez-G\u00f3mez","year":"2013","journal-title":"Nefrologia"},{"key":"R30-25-20230208","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/ki.2008.408","article-title":"Suppression of renin-angiotensin gene expression in the kidney by paricalcitol.","volume":"74","author":"Freundlich","year":"2008","journal-title":"Kidney Int"},{"key":"R31-25-20230208","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","article-title":"1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system.","volume":"110","author":"Li","year":"2002","journal-title":"J Clin Invest"},{"key":"R32-25-20230208","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1681\/ASN.2006050520","article-title":"Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy.","volume":"17","author":"Tan","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R33-25-20230208","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1681\/ASN.2007060666","article-title":"Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling.","volume":"19","author":"Tan","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R34-25-20230208","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1681\/ASN.2008091005","article-title":"Significance and management of proteinuria in kidney transplant recipients.","volume":"20","author":"Amer","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R35-25-20230208","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1111\/j.1600-6143.2007.02006.x","article-title":"Proteinuria after kidney transplantation, relationship to allograft histology and survival.","volume":"7","author":"Amer","year":"2007","journal-title":"Am J Transplant"},{"key":"R36-25-20230208","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/TP.0b013e31828719fb","article-title":"Low-grade proteinuria and microalbuminuria in renal transplantation.","volume":"96","author":"Halimi","year":"2013","journal-title":"Transplantation"},{"key":"R37-25-20230208","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000109398","article-title":"Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.","volume":"28","author":"Ross","year":"2008","journal-title":"Am J Nephrol"},{"key":"R38-25-20230208","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.V981427","article-title":"19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis.","volume":"9","author":"Martin","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"R39-25-20230208","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1067\/mlc.2002.122819","article-title":"Differential effects of 19-nor-1,25-dihydroxyvitamin D(2) and 1,25-dihydroxyvitamin D(3) on intestinal calcium and phosphate transport.","volume":"139","author":"Brown","year":"2002","journal-title":"J Lab Clin Med"},{"key":"R40-25-20230208","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2215\/CJN.03930808","article-title":"Progression of coronary artery calcification in renal transplantation and the role of secondary hyperparathyroidism and inflammation.","volume":"4","author":"Mazzaferro","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R41-25-20230208","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.atherosclerosis.2010.05.016","article-title":"Inflammation, coronary artery calcification and cardiovascular events in incident renal transplant recipients.","volume":"212","author":"Roe","year":"2010","journal-title":"Atherosclerosis"},{"key":"R42-25-20230208","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/ki.2011.207","article-title":"Short-term vitamin D receptor activation increases serum creatinine due to increased production with no effect on the glomerular filtration rate.","volume":"80","author":"Agarwal","year":"2011","journal-title":"Kidney Int"},{"key":"R43-25-20230208","first-page":"1070","article-title":"Safety and efficacy of oral calcitriol (1,25-dihydroxyvitamin D3) for the treatment of psoriasis.","volume":"134","author":"Perez","year":"1996","journal-title":"Br J Dermatol"},{"key":"R44-25-20230208","first-page":"98","article-title":"Renal function during calcitriol therapy in chronic renal failure.","volume":"33","author":"Bertoli","year":"1990","journal-title":"Clin Nephrol"},{"key":"R45-25-20230208","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4103\/0973-1482.38998","article-title":"Vitamin D and cancer.","volume":"3","author":"Ali","year":"2007","journal-title":"J Cancer Res Ther"},{"key":"R46-25-20230208","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1681\/ASN.V62257","article-title":"Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate.","volume":"6","author":"Gaspari","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"R47-25-20230208","first-page":"190","article-title":"The fate of bone after renal transplantation.","volume":"17","author":"Brandenburg","year":"2004","journal-title":"J Nephrol"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201505000-00025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:24:59Z","timestamp":1786130699000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201505000-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2013111185","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}